Madison Avenue Partners’s Arvinas ARVN Stock Holding History

Madison Avenue Partners’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500,000	Closed	-$3.68M	–	21
2025 Q2	$3.68M	Buy	+500,000	New	+$3.68M	0.25%	22

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Madison Avenue Partners's ARVN Position: Q3 2025 in Review

Madison Avenue Partners sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 500,000 shares — an estimated $3.68M sold.

Madison Avenue Partners first reported a position in ARVN in Q2 2025 and held it in 1 quarter. The position peaked at $3.68M in Q2 2025. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

Madison Avenue Partners reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
Madison Avenue Partners sold 500,000 Arvinas shares in Q3 2025, an estimated $3.68M.
Madison Avenue Partners first reported a position in Arvinas in Q2 2025 and held it in 1 quarter.
Madison Avenue Partners's Arvinas position peaked at $3.68M in Q2 2025.
211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Madison Avenue Partners's 13F filing for Q3 2025, filed 14 Nov 2025.